Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Chemical Abortion

Chemical Abortion

73 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
73 results
featured-image
Chemical Abortion

Slight Increase in Abortion Rate Largely Due to Surge in Chemical Abortion Nationwide

Today the U.S. Centers for Disease Control (CDC) released new data on abortion rates in 2018. The report generally comports with the preliminary survey of 38 individual state reports released by the Charlotte Lozier Institute (CLI)  in September 2020. CLI’s report similarly found a small increase in the aggregate number of abortions across the country and went deeper to analyze in which states this increase is predominantly occurring and suggest why the increase is happening.

charlotte-lozier-institute Charlotte Lozier Institute
November 25, 2020
ClosePlease login
Chemical Abortion

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States. In 2000, the Food and Drug Administration (FDA) approved the use of mifepristone, in conjunction with the drug misoprostol, as an abortion-inducing, two-drug process. By 2018, the Charlotte Lozier Institute estimates that 41% of U.S. abortions were chemically induced.

featured-image
Chemical Abortion

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

featured-image
Chemical Abortion

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health

A trend of mounting concern is occurring in abortion provision.  When elective induced abortion was legalized in the United States in 1973, one oft-cited motivation was to improve abortion’s safety, as it was frequently claimed that many women were injured and sometimes died from illegal abortions. Recently, abortion advocates have changed their strategy. Whereas once they claimed they wanted abortion to be “safe, legal and rare,” now they favor immediate access and convenience to abortion for all women experiencing unintended pregnancies, regardless of whether it might be more dangerous for a woman, or whether the law prohibits it. Thus, they have begun encouraging women to seek more dangerous, “self-managed” abortions.

featured-image
Chemical Abortion

#AbortionChangesYou: A Case Study to Understand the Communicative Tensions in Women’s Medication Abortion Narratives

Our study is one of the first to analyze women’s narratives after having had a medication abortion. Using relational dialectics theory, we conducted a case study of the nonpartisan website, Abortion Changes You.

featured-image
Chemical Abortion

CLI Responds to Halting of Abortion Pill Trial

“Pro-abortion researchers would rather continue to mislead women about the real risks of the abortion pill regimen Mifeprex than protect them from the risks of this dangerous drug,” said Dr. Tara Sander Lee, CLI’s Senior Fellow and Director of Life Sciences.

featured-image
Chemical Abortion

News Release: Abortion Activist Sues FDA over Regulation of Dangerous Drugs 

Today Charlotte Lozier Institute released the following response to a lawsuit seeking to stop U.S. Food and Drug Administration enforcement of the regulation of dangerous abortion drugs shipped into the United States from overseas.

featured-image
Chemical Abortion

State Regulation of Telemedicine Abortion and Court Challenges to Those Regulations

In this paper, Associate Scholar Amanda Stirone reviews statutes in 19 states regulating the practice of telemedicine abortion, then reviews litigation involving those regulations.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image